Published in BMJ on April 01, 1995
Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Neth Heart J (2007) 1.23
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. Hypertrophic cardiomyopathy can be treated but not cured. BMJ (1995) 0.89
Left ventricular hypertrophy is prevalent in Sprague-Dawley rats. Comp Med (2010) 0.89
Counselling issues in familial hypertrophic cardiomyopathy. J Med Genet (1998) 0.81
Parental knowledge and attitudes toward hypertrophic cardiomyopathy genetic testing. Pediatr Cardiol (2009) 0.77
Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med (1992) 4.20
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation. Circulation (1992) 2.67
Screening for hypertrophic cardiomyopathy. BMJ (1993) 2.31
Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N Engl J Med (1991) 2.11
Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med (1986) 2.00
Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol (1988) 1.77
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens A (1989) 1.43
Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. Br Heart J (1993) 1.15
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature (1982) 11.57
Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res (1983) 8.92
Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature (1992) 8.85
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (2001) 6.78
Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med (1996) 6.11
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70
Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr (1997) 5.47
The consultant episode: an unhelpful measure. BMJ (1992) 5.35
Invitation to attend a health check in a general practice setting: comparison of attenders and non-attenders. J R Coll Gen Pract (1988) 5.27
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J (2000) 4.99
Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain (1988) 4.69
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem (2001) 4.51
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet (1989) 4.42
Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res (2001) 4.15
NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esa1p and the ATM-related cofactor Tra1p. EMBO J (1999) 4.14
The genetic testing of children. Working Party of the Clinical Genetics Society (UK) J Med Genet (1994) 4.12
Diaphragm function and alveolar hypoventilation. Q J Med (1976) 3.94
X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet (1996) 3.90
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature (1990) 3.57
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature (1987) 3.51
The microbiology and pathogenesis of infective endocarditis. Br Heart J (1983) 3.36
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32
Efficient purchasing. BMJ (1993) 3.31
Consensus statement on the live organ donor. JAMA (2000) 3.29
Effect of community-based interventions on high-risk drinking and alcohol-related injuries. JAMA (2000) 3.24
A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal (1996) 3.18
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 3.17
The cardiomyopathies. Br Heart J (1972) 3.14
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases. Nat Genet (1996) 3.02
Measuring readmission rates. BMJ (1990) 3.01
Should we test children for "adult" genetic diseases? Lancet (1990) 2.97
Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child (1987) 2.95
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet (1996) 2.88
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis (2003) 2.85
Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood (1976) 2.76
The prevention of Huntington's chorea. The Milroy lecture 1985. J R Coll Physicians Lond (1986) 2.74
Brain spectrin, a membrane-associated protein related in structure and function to erythrocyte spectrin. Nature (1982) 2.74
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74
Prospective study of outcome in antenatally diagnosed renal pelvis dilatation. Arch Dis Child Fetal Neonatal Ed (1999) 2.73
Fatal injuries to bicyclists: the experience of Dade County, Florida. J Trauma (1983) 2.73
Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease. Br Heart J (1977) 2.68
Transient symptomatic hypotension in patients on simvastatin. Lancet (1989) 2.67
Genetic risks for children of women with myotonic dystrophy. Am J Hum Genet (1991) 2.65
Acute subvalvar mitral incompetence. Lancet (1966) 2.65
Accreditation in transoesophageal echocardiography: statement from the Association of Cardiothoracic Anaesthetists and the British Society of Echocardiography Joint TOE Accreditation Committee. Br J Anaesth (2003) 2.64
Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63
Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature (1988) 2.60
Guidelines, enthusiasms, uncertainty, and the limits to purchasing. BMJ (1995) 2.59
GISSI-3. Lancet (1994) 2.53
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49
Fulminating vibrio parahemolyticus septicemia. A syndrome of erythemia multiforme, hemolytic anemia, and hypotension. Arch Intern Med (1974) 2.46
Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology (2012) 2.45
The use of linked DNA polymorphisms for genotype prediction in families with Duchenne muscular dystrophy. J Med Genet (1983) 2.45
Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet (1993) 2.42
Unsuspected renal artery stenosis in peripheral vascular disease. BMJ (1990) 2.42
The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40
Early-onset dystrophia myotonica. Evidence supporting a maternal environmental factor. Lancet (1972) 2.40
Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus. Lancet (1991) 2.36
Unstable DNA sequence in myotonic dystrophy. Lancet (1992) 2.36
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res (1997) 2.34
Huntington's Chorea in South Wales. A genetic and epidemiological study. Clin Genet (1981) 2.31
High frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother (1988) 2.30
Changes in bone mineral content in male athletes. Mechanisms of action and intervention effects. JAMA (1996) 2.29
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet (1994) 2.25
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J (1985) 2.22
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis (2005) 2.21
Abnormalities of thyroid function in infants with Down syndrome. J Pediatr (1984) 2.19
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Studies of a DNA marker (G8) genetically linked to Huntington disease in British families. Hum Genet (1986) 2.18
Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet (1983) 2.16
Echocardiographic measurement of the normal adult right ventricle. Br Heart J (1986) 2.16
Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet (1993) 2.15
Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14
Why do women attend familial breast cancer clinics? J Med Genet (2000) 2.13
Fetal medicine and ultrasonography: a genetic perspective. Clin Radiol (1992) 2.12
Interaction of spontaneous respiration with artificial ventilation in preterm babies. J Pediatr (1983) 2.11
Development of a Cosmetic Procedure Screening Questionnaire (COPS) for Body Dysmorphic Disorder. J Plast Reconstr Aesthet Surg (2011) 2.10
Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10
Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker. Lancet (1987) 2.09
Adoption and genetic prediction for Huntington's disease. Lancet (1988) 2.09
Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08
Comparison of the manoeuvrability and ease of use of the Ambu aScope and Olympus re-usable fibrescope in a manikin. Anaesthesia (2011) 2.08
Can readmission rates be used as an outcome indicator? BMJ (1990) 2.07
Polycystic kidney disease re-evaluated: a population-based study. Q J Med (1991) 2.05
Linkage disequilibrium in Huntington's disease: an improved localisation for the gene. J Med Genet (1989) 2.05
Congenital myotonic dystrophy in Britain. I. Clinical aspects. Arch Dis Child (1975) 2.04
Anatomy, echocardiography, and normal right ventricular dimensions. Heart (2006) 2.03
Flosequinan: a new vasodilator for the treatment of heart failure. Br J Hosp Med (1993) 2.03
Regression of primary pulmonary hypertension. Br Heart J (1976) 2.03